National Health Investors NHI Gain (loss) on sale of derivatives
Gain (loss) on sale of derivatives at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfDerivatives.
The official record: National Health Investors’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about National Health Investors's gain (loss) on sale of derivatives.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is National Health Investors's gain (loss) on sale of derivatives?
- National Health Investors (NHI) reported gain (loss) on sale of derivatives of $0 in Q4 2025.
- How has National Health Investors's gain (loss) on sale of derivatives changed year-over-year?
- National Health Investors's gain (loss) on sale of derivatives decreased by 100.0% year-over-year, from $1.57M to $0.
- What does gain (loss) on sale of derivatives mean?
- This represents the realized gains or losses from the sale or settlement of derivative financial instruments used for hedging purposes. It reflects the effectiveness and outcome of the company's risk management strategies regarding interest rate or market volatility.